feed,title,long_url,short_url
🔐MarketWatch,Nektar's stock falls 44% after experimental therapy fails to work in melanoma patients,http://www.marketwatch.com/news/story/nektars-stock-falls-44-after/story.aspx?guid=%7BBAE8E40B%2DFB56%2D4516%2DB6D9%2D9D3034750122%7D&siteid=rss,https://on.mktw.net/3IawPDi
